BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8791997)

  • 1. An orally active antitumor cyclohexanediamine-Pt(IV) complex: trans,cis,cis-bis(n-valerato)(oxalato)(1R,2R-cyclohexane diamine)Pt(IV).
    Kizu R; Nakanishi T; Miyazaki M; Tashiro T; Noji M; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Kidani Y
    Anticancer Drugs; 1996 May; 7(3):248-56. PubMed ID: 8791997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new orally active antitumor 1R,2R-cyclohexanediamine-platinum(IV) complex: trans-(n-valerato)chloro(1R,2R-cyclohexanediamine) (oxalato)platinum(IV).
    Kizu R; Nakanishi T; Hayakawa K; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Tashiro T; Kidani Y
    Cancer Chemother Pharmacol; 1999; 43(2):97-105. PubMed ID: 9923814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand.
    Yamashita T; Hirose J; Noji M; Saito R; Tomida H; Kidani Y
    Biol Pharm Bull; 1993 Oct; 16(10):1014-8. PubMed ID: 8287030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of water solubility in the gastrointestinal absorption of trans-bis(n-valerato)(1R,2R-cyclohexanediamine)(oxalato)platinum(IV), an orally active antitumor platinum complex, and its analogs.
    Kizu R; Nakanishi T; Yamamoto S; Hayakawa K; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Kidani Y
    Anticancer Drugs; 1998 Feb; 9(2):167-74. PubMed ID: 9510503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of a new lipophilic platinum compound, trans-bis(n-valerato)(1R,2R-cyclohexanediamine)(oxalato)platinum(IV), in mice.
    Saegusa Y; Eriguchi M; Kidani Y; Matsuzawa A; Takeda Y
    Anticancer Res; 2001; 21(1A):245-52. PubMed ID: 11299742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of steroid-containing platinum (II) complexes of 1R,2R-cyclohexanediamine and 2-(aminomethyl)-cyclohexylamine isomers against leukemia L1210.
    Kidani Y; Suzuki K; Noji M; Tashiro T
    Biomed Pharmacother; 1989; 43(4):261-4. PubMed ID: 2790146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers.
    Pendyala L; Kidani Y; Perez R; Wilkes J; Bernacki RJ; Creaven PJ
    Cancer Lett; 1995 Nov; 97(2):177-84. PubMed ID: 7497460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
    Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
    Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
    Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
    J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structure and antitumor activity of a new water-soluble platinum complex, (1R,2R-cyclohexanediamine-N,N')[2-hydroxy-4-oxo-2-pentenoato(2-)-O2] platinum(II).
    Kawai H; Kitano Y; Mutoh M; Hata G
    Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):357-61. PubMed ID: 8500201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structure and antitumor activity of a water-soluble platinum complex, (1R,3R,4R,5R)-(-)-quinato(1R,2R-cyclohexanediamine)platinum (II).
    Hata G; Kitano Y; Kaneko T; Kawai H; Mutoh M
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1604-5. PubMed ID: 1394681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of l-OHP in mice.
    Mathé G; Kidani Y; Noji M; Maral R; Bourut C; Chenu E
    Cancer Lett; 1985 Jun; 27(2):135-43. PubMed ID: 4039973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and antitumor activities of 1R,2R-cyclohexanediamine Pt(II) complexes containing dicarboxylates.
    Noji M; Suzuki K; Tashiro T; Suzuki M; Harada K; Masuda K; Kidani Y
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):221-8. PubMed ID: 3594651
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes.
    Khokhar AR; al-Baker S; Shamsuddin S; Siddik ZH
    J Med Chem; 1997 Jan; 40(1):112-6. PubMed ID: 9016335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cytotoxic activity of dextran carrying cis-dichloro(cyclohexane-trans-l-1,2-diamine)platinum(II) complex.
    Ohya Y; Masunaga T; Baba T; Ouchi T
    J Biomater Sci Polym Ed; 1996; 7(12):1085-96. PubMed ID: 8880440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.
    Gandin V; Marzano C; Pelosi G; Ravera M; Gabano E; Osella D
    ChemMedChem; 2014 Jun; 9(6):1299-305. PubMed ID: 24715720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against (1R,2R)-cyclohexanediamineplatinum(II)-DNA adduct recognize the conformational differences of isomeric analogues of cyclohexanediamine.
    Yamada H; Kato T; Hirose J; Inagaki K; Noji M; Kidani Y
    Biochim Biophys Acta; 1990 Jul; 1049(3):298-302. PubMed ID: 2383586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro release of SM-11355, cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)] platinum(II) suspended in lipiodol.
    Kishimoto S; Noguchi T; Yamaoka T; Fukushima S; Takeuchi Y
    Biol Pharm Bull; 2000 May; 23(5):637-40. PubMed ID: 10823679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.